Financhill
Buy
72

INZY Quote, Financials, Valuation and Earnings

Last price:
$4.00
Seasonality move :
-20.12%
Day range:
$4.00 - $4.00
52-week range:
$0.72 - $6.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.12x
Volume:
--
Avg. volume:
1.3M
1-year change:
-10.91%
Market cap:
$258.2M
Revenue:
--
EPS (TTM):
-$1.69

Earnings Data

Next earnings date for INZY
Aug 06
2025
Most recent earnings per share
-$0.44
Missed by $0.04
(May 14/2025)
Consensus Estimate
-$0.40
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

INZY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 -- -- -- -- --
08/06/2025 Q2 -- -- -- -- --
05/14/2025 Q1 -- -- -$0.44 -$0.40 -$0.04
03/10/2025 Q4 -- -- -$0.42 -$0.37 -$0.05
11/05/2024 Q3 -- -- -$0.39 -$0.43 $0.04
08/06/2024 Q2 -- -- -$0.44 -$0.36 -$0.09
05/07/2024 Q1 -- -- -$0.38 -$0.34 -$0.04
03/12/2024 Q4 -- -- -$0.35 -$0.31 -$0.04
11/07/2023 Q3 -- -- -$0.29 -$0.30 $0.01
08/08/2023 Q2 -- -- -$0.35 -$0.40 $0.05
05/09/2023 Q1 -- -- -$0.40 -$0.41 $0.01
03/22/2023 Q4 -- -- -$0.42 -- --
11/10/2022 Q3 -- -- -$0.38 -- --
08/15/2022 Q2 -- -- -$0.38 -- --
05/10/2022 Q1 -- -- -$0.71 -- --
03/15/2022 Q4 -- -- -$0.17 -- --
11/09/2021 Q3 -- -- -$0.60 -- --
08/11/2021 Q2 -- -- -$0.53 -- --
05/12/2021 Q1 -- -- -$0.47 -- --
03/25/2021 Q4 -- -- -$0.48 -- --
11/12/2020 Q3 -- -- -$1.55 -- --
09/03/2020 Q2 -- -- -$0.47 -- --
03/31/2020 Q1 -- -- -$0.51 -- --
12/31/2019 Q4 -- -- -$0.43 -- --
09/30/2019 Q3 -- -- -$0.27 -- --
06/30/2019 Q2 -- -- -$0.28 -- --
03/31/2019 Q1 -- -- -$0.33 -- --

Inozyme Pharma Earnings Questions

  • How Much did Inozyme Pharma Generate in Revenue Last Quarter?

    Inozyme Pharma reported -- worth of top line sales in its most recent quarter.

  • Did Inozyme Pharma Beat Earnings Last Quarter?

    Inozyme Pharma announced earnings per share of -$0.44 which represents a miss of analyst forecast a -$0.40 per share.

  • Is Inozyme Pharma Profitable?

    Inozyme Pharma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Inozyme Pharma EPS Next Year?

    Inozyme Pharma's earnings are forecast to decrease from -$1.62 per share to -$1.51 per share next year representing a decrease of -23.46%.

  • When is Inozyme Pharma's Earnings Date?

    Inozyme Pharma's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Cisco Stock Be In 1 Year?
Where Will Cisco Stock Be In 1 Year?

Cisco Systems (NASDAQ: CSCO) rarely makes the front page of fintech…

Why Did David Tepper Sell Meta Stock?
Why Did David Tepper Sell Meta Stock?

Throughout 2024, David Tepper of Appaloosa Holdings sold more than…

The Market Tell Hiding in Plain Sight
The Market Tell Hiding in Plain Sight

Markets broadcast clues every day, but most traders tune in…

Stock Ideas

Buy
68
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 55x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
79
RYTM alert for Jul 10

Rhythm Pharmaceuticals [RYTM] is up 0.07% over the past day.

Sell
48
BGL alert for Jul 10

Blue Gold [BGL] is down 17.19% over the past day.

Buy
82
VRNA alert for Jul 10

Verona Pharma PLC [VRNA] is up 0.07% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock